May 26, 2013 10:56PM ET U.S. Markets Closed. S&P 500 -0.09% NASDAQ -0.05% Plans and Pricing

SciClone Pharmaceuticals (SCLN)

Add to Watchlists Create an Alert

4.86 -0.11 -2.21% NASDAQ May 24, 8:00PM BATS Real time Currency in USD

SciClone Pharmaceuticals News

China Biotech In Review: SciClone Pharma In-Licenses China Rights To Heart Failure Drug

May 19

4 Healthcare Stock Stories For Thursday Investing Wellness

May 16

SciClone (SCLN) Notes Possible Q1 Revenue Impact Due to NovaMed Accounting

Street Insider May 16

Sciclone (SCLN) Enters Licensing Agreement with Neucardin in East Asia

Street Insider May 16

SciClone Reports Anticipated Financial Results for the First Quarter 2013

Marketwired May 16

SciClone Pharmaceuticals, Inc. today reported its expectations regarding financial results for the quarter ended March 31, 2013.

SciClone and Zensun Enter Into a Licensing Agreement for Novel Chronic Heart Failure Drug Neucardin(TM) for the China Market

Marketwired May 16

SciClone Pharmaceuticals, Inc. today announced that the Company has entered into an agreement with Zensun Science & Technology Co., Ltd. granting SciClone a license and the exclusive rights in China, Hong ...

Socially Responsible Investing in Biotech and Pharmaceutical Companies: Expert Portfolio Manager Finny Kuruvilla Discusses His Construction Strategy with The Wall Street Transcript

May 16

SCICLONE PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Results of Operations an

May 16

Income Idea: 2 Undervalued Drug Makers With Rising Gross Profit Margins

May 10

Emerging Markets an Area of Opportunity for Global Generic Players: An Expert Analyst Gives His Take on the Generic Drug Space

May 2

SciClone Appoints PricewaterhouseCoopers LLP as Its Independent Registered Public Accounting Firm

noodls Apr 8

FOSTER CITY, CA -- (Marketwired) -- 04/08/13 -- SciClone Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced the Audit Committee of the Company's Board of Directors has appointed PricewaterhouseCoopers ...